GGrantIndex
← Search

PHASE I/II TRIAL OF ANTI-HIV ACTIVITY AMP; SAFETY OF MIFEPRISTONE (AACTG 5200)

$22,144M01FY2006RRNIH

Univ Of North Carolina Chapel Hill, Chapel Hill NC

Investigators

Linked publications & trials

View original record on NIH RePORTER →